We assessed correlations of NLRP1/NLRP3 expression with 57 immune cell markers in STAD to explore the potential mechanisms through which NLRP1/NLRP3 modulate immune cell infiltration. The gene discussed is NLRP3; the disease is gastric adenocarcinoma.